[Intranasal gonadorelin in the treatment of cryptorchism].
In 94 outpatients medium aged 4.16 years the LHRH analogues Gonadorelin had been administered for 4 weeks. 74 had monolateral cryptorchidism whereas 18 had bilateral cryptorchidism. The results indicate that Gonadorelin has a role in treating cryptorchidism. The Authors suggest, on its experience, that the Gonadorelin should be the first choice of treatment of cryptorchidism.
Beretta
G
G
Zanollo
A
A
D000281:Administration, Intranasal; D002648:Child; D002675:Child, Preschool; D003456:Cryptorchidism / Q000188:drug therapy*; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D008297:Male
D007987:Gonadotropin-Releasing Hormone
La Gonadorelina per via intranasale nel trattamento del criptorchidismo.